Orian Sh.M. Ltd. (TLV:ORIN)

Regulus Therapeutics Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	451	346	338	499	738	614
Market Cap Growth	48.07%	2.55%	-32.37%	-32.34%	20.15%	151.80%
Enterprise Value	1,481	1,164	1,113	1,228	1,308	964
Last Close Price	26.69	20.50	19.39	28.77	42.17	35.12
PE Ratio	52.88	15.60	19.34	12.38	102.03	65.92
PS Ratio	0.42	0.34	0.37	0.39	0.77	0.94
PB Ratio	1.21	0.99	1.02	1.64	3.13	2.64
P/TBV Ratio	1.38	1.15	1.20	1.97	4.01	3.35
P/FCF Ratio	5.23	4.21	29.37	-	-	-
P/OCF Ratio	3.55	2.79	3.89	4.22	12.23	12.52
EV/Sales Ratio	1.38	1.13	1.22	0.97	1.36	1.48
EV/EBITDA Ratio	10.81	11.70	17.48	15.91	23.08	17.28
EV/EBIT Ratio	25.97	19.30	41.78	31.17	40.58	25.73
EV/FCF Ratio	17.18	14.15	96.72	-	-	-
Debt / Equity Ratio	2.96	3.18	2.77	2.54	3.32	1.86
Debt / EBITDA Ratio	8.15	8.12	9.37	7.08	9.81	5.62
Debt / FCF Ratio	12.84	13.52	79.94	-	-	-
Asset Turnover	0.68	0.66	0.66	0.93	0.93	0.87
Quick Ratio	1.05	0.96	1.11	0.90	1.09	1.54
Current Ratio	1.08	0.99	1.19	0.92	1.10	1.56
Return on Equity (ROE)	2.44%	6.55%	5.51%	14.09%	3.03%	5.31%
Return on Assets (ROA)	2.21%	2.42%	1.20%	1.80%	1.96%	3.11%
Return on Capital (ROIC)	2.54%	2.76%	1.41%	2.21%	2.42%	3.93%
Return on Capital Employed (ROCE)	4.10%	4.50%	2.30%	4.10%	3.60%	6.20%
Earnings Yield	1.93%	6.41%	5.17%	8.08%	0.98%	1.52%
FCF Yield	19.12%	23.73%	3.40%	-2.52%	-14.43%	-10.83%
Dividend Yield	2.22%	2.89%	-	1.03%	-	-
Payout Ratio	116.81%	44.80%	-	12.75%	-	-
Buyback Yield / Dilution	-0.91%	-	-0.34%	0.01%	-24.64%	-2.13%
Total Shareholder Return	1.22%	2.89%	-0.34%	1.04%	-24.64%	-2.13%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.